Status:
UNKNOWN
Ultrapure Water System for Hemodialysis Therapy
Lead Sponsor:
Tel Aviv Medical Center
Conditions:
The Change of Biomarkers CRP, CBC With the Use of Ultra Pure Water System for
Hemodialysis.
Eligibility:
All Genders
18+ years
Brief Summary
We wish to compare the effect of very clean water used for dialysis therapy (i.e ultrapure water) in comparison with the use of conventional water which are used in most dialysis units worldwide. To t...
Detailed Description
In observational studies, the use of very pure dialysis solution has been suggested to reduce the plasma level of CRP, IL-6 ; to improve the response to anemia to erythropoietin therapy ; to promote b...
Eligibility Criteria
Inclusion
- chronic hemodialysis therapy thrice weekly \> 3 months of therapy
- Signed an informed consent -
Exclusion
- Enrolled to other study
- Ongoing infection -
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01400126
Start Date
August 1 2011
End Date
January 1 2013
Last Update
July 22 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.